"Phase I, randomized, double-blind, placebo-controlled, crossover study to compare the pharmacokinetics of a single oral dose of a new zaleplon formulation (SKP-1041) and open label zaleplon in healthy elderly subjects."

Phase I, randomized, double-blind, placebo-controlled, crossover study to compare the pharmacokinetics of a single oral dose of a new zaleplon formulation (SKP-1041) and open label zaleplon in healthy elderly subjects.

Greenblatt DJ, Danjou P, Luthringer R, Metzger D, Otmani S, Pross N, Osbakken M, McCormick A, Walsh J.

APSS 2010 (San Antonio, Texas, USA), June 5-9, 2010 (Poster)

06/05/2010